Active Ingredients (In Each Extended-Release Bi-Layer Tablet)
Guaifenesin 1200 mg
Pseudoephedrine HCl 120 mg
The following Structured Product Label (SPL) was submitted to the FDA by L. Perrigo Company for the product Mucus D (NDC 0113-8911). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each extended-release bi-layer tablet), purposes, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 1200 mg
Pseudoephedrine HCl 120 mg
Expectorant
Nasal Decongestant
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
carbomer homopolymer type B, colloidal silicon dioxide, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
Compare to Maximum Strength Mucinex® D active ingredients
MAXIMUM STRENGTH
mucus-D
Guaifenesin 1200 mg>>Expectorant/Pseudoephedrine Hydrochloride 120 mg>>Nasal Decongestant Extended-Release Tablets
RELIEVES NASAL & CHEST CONGESTION
Clears Nasal and Sinus Congestion
Thins and Loosens Mucus
Immediate and Extended Release
12 HOUR
actual size
24 EXTENDED-RELEASE TABLETS
* Please review the disclaimer below.